ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,309, issued on Oct. 27, was assigned to LIFESEARCH (Toulouse, France), LIFESEARCH INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (Paris) and UNIVERSITE PAUL SABATIER TOULOUSE III (Toulouse, France).
"Treatment of hepatic and cardiovascular disorders" was invented by Laurent Martinez (Toulouse, France), Souad Najib (Saint-Leon, France) and Nabil Sioufi (Los Angeles).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a peptide and its use as a medicament, in particular in the treatment of metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), cardiovascular disease (CVD) or cholestatic liver dise...